Internal Medicine · Harbor City, CA
NPI
1306285796
Since 2013
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
25975 Normandie Ave
Harbor City, CA, 90710
Phone (310) 325-5111
Groups this clinician bills Medicare through
Medicare paid, 2023
$4,139
59 services
Medicare patients, 2023
15
Average age 70
Drug cost, 2024
$198K
3,338 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ling L Cheng prescribed most often to Medicare patients was Atorvastatin Calcium, with 264 prescriptions and refills. In total Ling L Cheng wrote 3,338 Medicare prescriptions that cost $198K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 264 | 318 | 48 | $5,567 |
| Amlodipine Besylate Generic | 133 | 165 | 25 | $1,896 |
| Potassium Chloride Generic | 115 | 121 | 23 | $2,147 |
| Furosemide Generic | 91 | 99 | 19 | $830 |
| Enoxaparin Sodium Generic | 85 | 85 | 12 | $7,522 |
| Pantoprazole Sodium Generic | 77 | 88 | 18 | $1,973 |
| Eliquis Apixaban | 75 | 79 | Under 11 | $25K |
| Lactulose Generic | 75 | 75 | 33 | $1,861 |
| Tamsulosin Hcl Generic | 72 | 92 | 14 | $2,284 |
| Hydralazine Hcl Generic | 72 | 77 | 17 | $2,361 |
| Lisinopril Generic | 72 | 96 | 18 | $1,174 |
| Humulin R Insulin Regular, Human | 71 | 75 | 15 | $3,386 |
| Carvedilol Generic | 65 | 70 | Under 11 | $1,568 |
| Omeprazole Generic | 62 | 90 | 20 | $1,093 |
| Memantine Hcl Generic | 58 | 66 | 14 | $1,942 |
Brand drugs: 412 claims; generic drugs: 2,887 claims; opioid claims: 33.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ling L Cheng were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.